Ftse Mib
33.787,00
-1,78%
DAX
19.969,86
-1,44%
S&P 500
5.867,08
-0,09%
NASDAQ
19.372,77
-0,10%
Bitcoin
97.174,58
-0,29%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioCryst Pharmaceuticals Inc (BCRX) BioCryst Pharmaceuticals Inc (BCRX) Notizie

BioCryst Pharmaceuticals Inc

BCRX
7,365
0,055 (0,75%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:23:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:23EDGAR2Form 144 - Report of proposed sale of securities
04/12/202422:15GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
02/12/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202408:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Ireland
06/11/202413:00GLOBEBioCryst to Present at Upcoming Investor Conferences
05/11/202423:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/11/202413:06EDGAR2Form 8-K - Current report
04/11/202413:00GLOBEBioCryst Reports Third Quarter 2024 Financial Results and..
24/10/202414:00GLOBEBioCryst Presents New Real-World Evidence Showing High..
21/10/202413:00GLOBEBioCryst to Report Third Quarter 2024 Financial Results on..
14/10/202413:00GLOBEBioCryst to Present New Real-World Evidence Showing..
10/10/202413:00GLOBEBioCryst to Present New Real-World Evidence on Long-Term..
03/10/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
02/10/202413:06EDGAR2Form 8-K - Current report
02/10/202413:00GLOBEBioCryst Begins Enrollment in Phase 1 Trial Evaluating..
30/9/202413:11EDGAR2Form 8-K - Current report
30/9/202413:00GLOBEU.S. Government Awards BioCryst $69 Million RAPIVAB®..
17/9/202413:00GLOBEBioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA)..
10/9/202418:09EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/9/202408:00GLOBEBioCryst Presents New ORLADEYO® (berotralstat) Data at 7th..
05/9/202413:00GLOBEBioCryst Appoints Dr. Donald Fong Chief Medical Officer
04/9/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202413:00GLOBEBioCryst to Present at Upcoming Investor Conferences
06/8/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/8/202413:05EDGAR2Form 8-K - Current report
05/8/202413:00GLOBEBioCryst Reports Second Quarter 2024 Financial Results and..
05/8/202411:46IHMARKETNEWSU.S. Index Futures and Oil Prices Plunge on Recession..
02/8/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
22/7/202413:00GLOBEBioCryst to Report Second Quarter 2024 Financial Results on..
02/7/202413:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
17/6/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:14EDGAR2Form 144 - Report of proposed sale of securities
14/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:08EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 7,31 Min: 7,22 Max: 7,48
Chiusura: 7,31

La tua Cronologia

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network